title: Effects of calcium in continuous cardioplegia on myocardial protection.
abstract: The effects of calcium (Ca) on a hyperkalemic cardioplegic solution for continuous cardioplegia were examined in an isolated perfused working rat heart model. The coronary arteries were perfused with a modified Krebs-Henseleit bicarbonate buffer (K-H) solution, containing various concentrations of Ca (0.1, 0.6, 1.2, and 2.5 mmol/l) and a high concentration of potassium (20 mmol/l), for 180 min, after which cardiac arrest was induced at 37 degrees C for 180 min. Cardiac function and creatine kinase (CK) were measured. In the control group, K-H solution was infused in place of the cardioplegic solution, and cardiac arrest was not induced. No significant differences were observed between the groups infused with the K-H solution containing Ca concentrations of 0.6, 1.2, and 2.5 mmol/l in the percent recovery of aortic flow (82.1 +/- 2.9%, 80.6 +/- 2.0%, and 71.5 +/- 3.7% (mean +/- SEM) respectively) or in the recovery of other indices of cardiac function, or in CK leakage. There were also no significant differences in the recovery of cardiac function and CK leakage between these groups and the control group. In the Ca 0.1 mmol/l group, however, the characteristic Ca paradox was observed. These findings suggest that if the Ca concentration in a cardioplegic solution is higher than 0.6 mmol/l during continuous cardioplegia, excellent cardioprotective effects will be achieved.
authors.affiliation: Second Department of Surgery, Tottori University Faculty of Medicine, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Takemoto
authors.forename: H
authors.initials: H
authors.lastname: Kuroda
authors.forename: Y
authors.initials: Y
authors.lastname: Nakamura
authors.forename: T
authors.initials: T
authors.lastname: Ichiba
authors.forename: N
authors.initials: N
authors.lastname: Matsuda
authors.forename: Y
authors.initials: Y
authors.lastname: Ashida
authors.forename: T
authors.initials: T
authors.lastname: Hamasaki
authors.forename: Y
authors.initials: Y
authors.lastname: Hara
authors.forename: S
authors.initials: S
authors.lastname: Ishiguro
authors.forename: T
authors.initials: T
authors.lastname: Mori
mesh_terms: D000818:Animals; D002118:Calcium / Q000494:pharmacology*; D002314:Cardioplegic Solutions / Q000737:chemistry* / Q000494:pharmacology; D003402:Creatine Kinase / Q000378:metabolism; D005947:Glucose / Q000737:chemistry; D006324:Heart Arrest, Induced / Q000379:methods*; D008297:Male; D015428:Myocardial Reperfusion Injury / Q000517:prevention & control*; D009206:Myocardium / Q000378:metabolism / Q000648:ultrastructure; D010477:Perfusion; D051381:Rats; D017208:Rats, Wistar; D014325:Tromethamine / Q000737:chemistry
chemical_list: D002314:Cardioplegic Solutions; C074097:Krebs-Henseleit solution; D014325:Tromethamine; D003402:Creatine Kinase; D005947:Glucose; D002118:Calcium